Tag Archives: intellectual property

Myriad Oral Arguments – Section 101 vs. Chemistry 101?

After listening to the IPO webinar and reading the detailed account by Kevin Noonan in PatentDocs on the Myriad oral arguments, I was somewhat heartened to “hear” the Fed. Cir. panel moving toward “getting it” regarding what an isolated DNA … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , | 2 Comments

No USPTO Shutdown For Now

A Message from Director David Kappos Dear Colleagues, As you know, the Administration is working diligently with Congress to ensure that the federal government remains open and continues to do its work on behalf of the American people. However, I … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , | Leave a comment

PTO Issues Final Rule to Implement Prioritized Examination Track (Track I)

The following is from the Schwegman, Lundberg & Woessner Newsletter, April 6, 2011. The Patent and Trademark Office on April 4, 2011, issued a final rule to implement prioritized examination upon an applicant’s request and payment of a $4,000 request … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , , , , | Leave a comment

Federal Court Hears Myriad Gene Case This Morning

The following is a guest post from Ann McCrackin. I attended oral arguments at the CAFC on Monday for Association for Molecular Pathology v. Myriad Genetics, Inc.   The three-judge panel included Judge Bryson, Judge Lourie and Judge Moore.  Most of the … Continue reading

Posted in Burden of Proof | Tagged , , , , , , , , , , , , , , , , | Leave a comment